Abstract
Due to chronic intraocular inflammation, various irreversible changes in the eye, such as cataract, glaucoma, macular edema, intraocular neovascularization and proliferative intraocular changes are observed in sarcoidosis patients. We need to pay special attention to these ocular complications. The basic therapy for uveitis associated with sarcoidosis is a combination of topical steroid and mydriatics. There are several types of topical steroid therapy, including eye drops, subconjunctival injection, subtenon injection, retrobulbar injection and vitreous cavity injection. Recently, the pars plana steroid implant was invented and a medical trial study using this device for refractory uveitis is ongoing in Japan. Systemic steroid therapy was performed for ocular sarcoidosis patients, but limited to cases resistant to topical steroid therapy. Moreover, surgical management has come to be selected for severe complications.
